Similar articles for PMID: 28501075

Year	Number of Results
1996	1
2002	1
2006	1
2007	17
2008	26
2009	10
2010	2
2011	5
2012	2
2013	3
2014	2
2015	7
2016	26
2017	23
2018	24
2019	22
2020	20
2021	13
2022	7
2023	2
2024	0

1

Gadolinium Retention and Toxicity-An Update.

Ramalho M, Ramalho J, Burke LM, Semelka RC. Ramalho M, et al. Adv Chronic Kidney Dis. 2017 May;24(3):138-146. doi: 10.1053/j.ackd.2017.03.004. Adv Chronic Kidney Dis. 2017. PMID: 28501075 Review.

2

Gadolinium toxicity and treatment.

Ramalho J, Ramalho M, Jay M, Burke LM, Semelka RC. Ramalho J, et al. Magn Reson Imaging. 2016 Dec;34(10):1394-1398. doi: 10.1016/j.mri.2016.09.005. Epub 2016 Sep 28. Magn Reson Imaging. 2016. PMID: 27693607 Review.

3

Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review.

Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Rudnick MR, et al. Am J Kidney Dis. 2021 Apr;77(4):517-528. doi: 10.1053/j.ajkd.2020.07.012. Epub 2020 Aug 27. Am J Kidney Dis. 2021. PMID: 32861792 Review.

4

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.

Rogosnitzky M, Branch S. Rogosnitzky M, et al. Biometals. 2016 Jun;29(3):365-76. doi: 10.1007/s10534-016-9931-7. Epub 2016 Apr 6. Biometals. 2016. PMID: 27053146 Free PMC article. Review.

5

Gadolinium Deposition and Chronic Toxicity.

Ramalho J, Ramalho M. Ramalho J, et al. Magn Reson Imaging Clin N Am. 2017 Nov;25(4):765-778. doi: 10.1016/j.mric.2017.06.007. Epub 2017 Sep 8. Magn Reson Imaging Clin N Am. 2017. PMID: 28964466 Review.

6

Gadolinium-based contrast agents - what is the evidence for 'gadolinium deposition disease' and the use of chelation therapy?

Layne KA, Wood DM, Dargan PI. Layne KA, et al. Clin Toxicol (Phila). 2020 Mar;58(3):151-160. doi: 10.1080/15563650.2019.1681442. Epub 2019 Oct 30. Clin Toxicol (Phila). 2020. PMID: 31663374 Review.

7

Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.

Pedersen M. Pedersen M. J Magn Reson Imaging. 2007 May;25(5):881-3. doi: 10.1002/jmri.20983. J Magn Reson Imaging. 2007. PMID: 17457808 No abstract available.

8

Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist's Primer.

Mathur M, Jones JR, Weinreb JC. Mathur M, et al. Radiographics. 2020 Jan-Feb;40(1):153-162. doi: 10.1148/rg.2020190110. Epub 2019 Dec 6. Radiographics. 2020. PMID: 31809230 Review.

9

Gadolinium tissue deposition in brain and bone.

Murata N, Murata K, Gonzalez-Cuyar LF, Maravilla KR. Murata N, et al. Magn Reson Imaging. 2016 Dec;34(10):1359-1365. doi: 10.1016/j.mri.2016.08.025. Epub 2016 Oct 5. Magn Reson Imaging. 2016. PMID: 27720805 Review.

10

Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.

Layne KA, Dargan PI, Archer JRH, Wood DM. Layne KA, et al. Br J Clin Pharmacol. 2018 Nov;84(11):2522-2534. doi: 10.1111/bcp.13718. Epub 2018 Aug 17. Br J Clin Pharmacol. 2018. PMID: 30032482 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

191 results

Results by year